Vaccine findings a 'landmark moment' says head of Oxford tri

The head of Oxford's vaccine trial team has said the findings of pharmaceutical firm Pfizer marks a "landmark moment" against the coronavirus pandemic. Pfizer announced on Monday that interim findings from its Covid-19 vaccine study showed the jab to be more than 90% effective in preventing the disease. Professor Andrew Pollard, from the Oxford Vaccine Group, praised the results, but said they do not have an impact on what his team are working on. Oxford University teamed up with AstraZeneca to develop their own Covid-19 vaccine.